{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-069021","form_type":"8-K","ticker":"MOVE","cik":"0001734750","company_name":"Corvex, Inc.","filed_at":"2024-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.354955+00:00","generated_at":"2026-05-31T09:22:31.655733+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Movano Health Q2 2024 operating loss narrows to $6.4M; Evie Ring back in stock Sept 17","bullets":["Operating loss of $6.4M improved from $7.4M in Q2 2023; no revenue reported as refunds offset deferred revenue.","Shipped 1,837 Evie Rings in Q2; cash and equivalents $16.9M at June 30, 2024.","Evie Ring expected back in stock September 17, 2024; brand partnership with Heidi D'Amelio announced.","FDA live meeting scheduled mid-August for EvieMED 510(k) clearance; B2B opportunities with pharma and payor advancing.","April 2024 $24.1M private placement closed with tier-1 medical device company investment."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-069021","json":"https://secwatch.observer/filing/0001213900-24-069021.json","markdown":"https://secwatch.observer/filing/0001213900-24-069021.md","text":"https://secwatch.observer/filing/0001213900-24-069021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1734750/000121390024069021/0001213900-24-069021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1734750/000121390024069021/ea0211408-8k_movano.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:22:31.655733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}